Effects of Fractalkine Receptor Variants on Common Carotid Artery Intima-Media Thickness
- 1 June 2006
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 37 (6) , 1558-1561
- https://doi.org/10.1161/01.str.0000221803.16897.22
Abstract
Background and Purpose— Fractalkine receptor (CX3CR1) plays a key role during atherogenesis. CX3CR1 has 2 common coding polymorphisms, namely V249I and T280M, that have been associated with interindividual differences in susceptibility to atherosclerosis. In the present study, we investigated the possible association between CX3CR1variants and intima-media thickness (IMT). Methods— We genotyped 1256 samples from the Progression of Lesions in the Intima of the Carotid (PLIC) study (a prospective population-based study) for the presence of the V249 and the M280 variants of CX3CR1. Results— Significantly reduced IMT was observed in subjects with the MM280 genotype (0.57±0.12 mm) compared with subjects with the TT (0.65±0.14 mm) or the TM (0.65±0.13 mm) genotype. No difference in IMT was observed within carrier of the II249, VI249, or VV249 genotype. Subjects with combined genotype VI249/MM280 and II249/MM280 showed a reduced IMT. Conclusions— The presence of the M280 polymorphism of the fractalkine receptor is associated with a decreased common carotid artery IMT, whereas the presence of the I249 polymorphism does not play a major role on the progression of carotid atherosclerosis.Keywords
This publication has 13 references indexed in Scilit:
- Effect of the Toll‐like receptor 4 (TLR‐4) variants on intima‐media thickness and monocyte‐derived macrophage response to LPSJournal of Internal Medicine, 2005
- Opposite effects of CX3CR1 receptor polymorphisms V249I and T280M on the development of acute coronary syndromeThrombosis and Haemostasis, 2005
- Internal Carotid Artery Occlusive Disease and Polymorphisms of Fractalkine Receptor CX3CR1Stroke, 2004
- Smooth Muscle Cells in Human Atherosclerotic Plaques Express the Fractalkine Receptor CX 3 CR1 and Undergo Chemotaxis to the CX 3 C Chemokine Fractalkine (CX 3 CL1)Circulation, 2003
- Decreased Atherosclerotic Lesion Formation in CX3CR1/Apolipoprotein E Double Knockout MiceCirculation, 2003
- Characterization of fractalkine (CX3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular diseaseCardiovascular Pathology, 2002
- Dual Functions of Fractalkine/CX3C Ligand 1 in Trafficking of Perforin+/Granzyme B+ Cytotoxic Effector Lymphocytes That Are Defined by CX3CR1 ExpressionThe Journal of Immunology, 2002
- Polymorphism in the fractalkine receptor CX3CR1 as a genetic risk factor for coronary artery diseaseBlood, 2001
- Rapid Progression to AIDS in HIV + Individuals with a Structural Variant of the Chemokine Receptor CX 3 CR1Science, 2000
- A new class of membrane-bound chemokine with a CX3C motifNature, 1997